OSEBX1 963,65+0,00 %
EQNR371,80+1,03 %
DNB280,60+0,97 %
MOWI205,40+1,18 %
Brent$111,44+0,94 %
Gold$4 574,60−1,19 %
USD/NOK9,2722+0,10 %
EUR/NOK10,8802+0,12 %
SPX7 209,01+0,00 %
NDX27 452,12+0,00 %
LIVE · 09:55 UTC

Green Earth Institute Co Ltd

9212 · Oil, Gas & Consumable Fuels · Japan

Profile
Ticker9212
RIC9212.T
ISINJP3274120009
IssuerGreen Earth Institute Co Ltd
SectorEnergy
IndustryOil, Gas & Consumable Fuels
Sub-industrySpecialty Chemicals
HeadquartersShinjuku, Japan
Country of issuerJapan
Founded2011-09-01
Employees47
Total share float7,287,700
Holders (C/S)4,110
AuditorMoore Mirai & Co.
CEO / managementMr. Tomohito Ihara
Business Description

Green Earth Institute Co Ltd is a Japan-based company mainly engaged in the development and commercialize of green chemicals utilizing biorefinery technology. The Company develops highly efficient fermentation technology utilizing microorganisms called coryneform bacteria as core technology. The Company does not own production equipment and focuses on two business models: research and development business and license and product sales business. Biorefinery technology has four characteristics: growth-independent bioprocess, improvement of microorganisms by gene recombination, efficient scale-up using computational fluid dynamics, and repeated use.

ESG · Risk Indicators
Controversies score
Governance pillar
Social pillar
Insider trading score
Industry Substrate · Chemicals
Signals to watch
  • Feedstock spread (price - input cost) (leading)
  • Plant utilization rate (coincident)
  • End-market demand (auto, construction, agri) (leading)
  • Inventory destocking/restocking cycles (coincident)
  • Specialty volume growth (trend)
Geopolitical drivers
  • Energy/feedstock cost (Russia gas, Middle East oil) · exposure: high
  • Trade tariffs on chemical exports/imports · exposure: medium-high
  • Environmental regulation (EU REACH, US EPA) · exposure: high
  • Agricultural policy (subsidies, fertilizer demand) · exposure: medium for agri-chem
Industry KPIs
  • EBITDA margin % — 5-15% commodity; 15-25% specialty
  • Capex/sales % — watch trough vs peak
  • Plant utilization % — 82-92% healthy; <80% pressure
  • ROIC — 10%+ specialty; 6-10% commodity through cycle
  • Net debt / EBITDA — below 3.0x healthy; cyclical buffer
Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.